Filing Details

Accession Number:
0001493152-22-035281
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-12-13 11:46:41
Reporting Period:
2022-12-09
Accepted Time:
2022-12-13 11:46:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1335105 Lixte Biotechnology Holdings Inc. LIXT Pharmaceutical Preparations (2834) 202903526
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1650389 Eric Forman 680 E. Colorado Blvd., Suite 180
Pasadena CA 91101
Vice President And Coo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-12-09 10,000 $0.60 0 No 4 P Indirect ERIC FORMAN REVOCABLE TRUST
Common Stock Acquisiton 2022-12-09 5,000 $0.63 0 No 4 P Indirect ERIC FORMAN REVOCABLE TRUST
Common Stock Acquisiton 2022-12-09 1,112 $0.63 0 No 4 P Indirect ERIC FORMAN REVOCABLE TRUST
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect ERIC FORMAN REVOCABLE TRUST
No 4 P Indirect ERIC FORMAN REVOCABLE TRUST
No 4 P Indirect ERIC FORMAN REVOCABLE TRUST
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 0 Direct